Angioedema is a rare but potentially life-threatening adverse effect of angiotensin-converting enzyme inhibitors. A patient who presented with facial angioedema four months after initiating antihypertensive treatment with enalapril is described. Angioedema due to angiotensinconverting enzyme inhibitors usually appears during the first weeks of treatment. Late-onset angioedema is often unrecognized.